Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment

Non-small cell lung cancer (NSCLC) is one of the most common malignancies in the world. Although extensive studies showed that luteolin exhibited antitumor effects against NSCLC, the mechanism has not been fully established. In the present study, we found that luteolin significantly reduced the expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Qian, Zhang, Minda, Ying, Qidi, Xie, Xin, Yue, Shuwen, Tong, Bending, Wei, Qing, Bai, Zhaoshi, Ma, Lingman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399355/
https://www.ncbi.nlm.nih.gov/pubmed/30833546
http://dx.doi.org/10.1038/s41419-019-1447-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399355/
https://www.ncbi.nlm.nih.gov/pubmed/30833546
http://dx.doi.org/10.1038/s41419-019-1447-y

Ejemplares similares